State of the nation, or should that be, what state is the nation in?

The COVID-19 pandemic has changed the UK business landscape, but has it been a blessing or a curse? Will the UK life sciences sector be in a stronger position to weather future upheaval due to Brexit, having adapted to a post-pandemic world?


RICHARD HEBDON | Head of Health & Medicine, Ageing Society, Health & Nutrition Sector | Innovate UK


EDDY LITTLER | Chief Operating Officer | ReViral
BEVERLEY CARR | Chief Business Officer | Achilles
JASON LACOMBE | Chief Executive Officer | Veratrak
NOOR SHAKER | Chief Executive Officer | GlamorousAI
OLIVIA CHAMPION | Founder and Chief Executive Officer | BioSystems Technology
TOM MANDER | Chief Operating Officer | Domainex